Mickle Christal M M.'s most recent trade in Zevra Therapeutics Inc was a trade of 77,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Mickle Christal M M. | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 77,000 | 77,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Christal M M. Mickle | Chief Product Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |